Long‐term survival following the development of heart failure in an elderly hypertensive population

BACKGROUND Available data on the prognosis of heart failure (HF) patients are predominantly limited to patients diagnosed at time of hospitalization. AIMS To describe the long-term survival of incident HF patients and identify clinical characteristics associated with mortality. METHODS The Second Australian National Blood Pressure Study (ANBP2) randomized 6083 hypertensive subjects aged 65-84 years to angiotensin-converting enzyme (ACE) inhibitor or thiazide diuretic-based therapy and followed them for a median of 4.1 years. One hundred forty-five participants who developed HF and 5938 who remained free from HF during the trial period were followed for a median of 6.7 years during a posttrial follow-up. RESULTS Three quarters, 110 (76%) of HF patients had died at the end of the follow-up. The five- and ten-year survival rates following HF diagnosis during the trial period were 37% and 15%, respectively, in men, compared with 60% and 33%, respectively, in women. In non-heart failure participants, the five- and ten-year survival rates, following enrollment into the study, were 92% and 76%, respectively. Mortality following HF diagnosis increased with advancing age (HR = 1.09, 95% CI: 1.04-1.33). In addition, male gender and preexisting diabetes were predictive of mortality, while ACE inhibitor-based therapy for the initial trial was associated with 39% decrease (HR = 0.61, 95% CI: 0.41-0.91) in mortality compared with a thiazide diuretic-based regimen. CONCLUSIONS Long-term survival in elderly HF patients is poor, especially in men. Mortality in HF patients increased progressively with advancing age, while allocation to the ACE inhibitor-based regimen for the initial trial significantly improved HF outcome.

[1]  C. Reid,et al.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.

[2]  P. Ponikowski,et al.  Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. , 2008, European heart journal.

[3]  Colin Simpson,et al.  Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People , 2009, Circulation.

[4]  C. Reid,et al.  Prediction of Cardiovascular Events in Subjects in the Second Australian National Blood Pressure Study , 2010, Hypertension.

[5]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[6]  E. Boersma,et al.  Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients , 2012, European heart journal.

[7]  V. Hasselblad,et al.  Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. , 2005, Journal of cardiac failure.

[8]  C. Forsblom,et al.  Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study , 2011, BMJ : British Medical Journal.

[9]  M. Woodward,et al.  Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes , 2014, Diabetologia.

[10]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[11]  R. Ferrari,et al.  The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review , 2013, Expert review of cardiovascular therapy.

[12]  D. McManus,et al.  Improved Survival After Heart Failure: A Community‐Based Perspective , 2013, Journal of the American Heart Association.

[13]  A. Roalfe,et al.  Ten‐year prognosis of heart failure in the community: follow‐up data from the Echocardiographic Heart of England Screening (ECHOES) study , 2012, European journal of heart failure.

[14]  S. Stewart,et al.  Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue , 2016, BMC Health Services Research.

[15]  A. Hoes,et al.  Comorbidity drives mortality in newly diagnosed heart failure: a study among geriatric outpatients. , 2012, Journal of cardiac failure.

[16]  C. Reid,et al.  Australian comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly (ANBP2): objectives and protocol. Management Committee on behalf of the High Blood Pressure Research Council of Australia. , 1997, Clinical and experimental pharmacology & physiology.

[17]  Albert Hofman,et al.  Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. , 2004, European heart journal.

[18]  M. Domanski,et al.  The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. , 2003, Journal of the American College of Cardiology.

[19]  P. Kowey,et al.  Predictors of adverse outcome among patients with hypertension and coronary artery disease. , 2006, Journal of the American College of Cardiology.

[20]  J. Cohn,et al.  Influence of Age on Mechanisms and Prognosis of Heart Failure , 1993, Circulation.

[21]  R. Goldberg,et al.  A Contemporary Population-Based Perspective , 2017 .

[22]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[23]  N. Lamblin,et al.  Influence of diabetes mellitus on heart failure risk and outcome , 2003, Cardiovascular diabetology.

[24]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[25]  G. Fonarow,et al.  Epidemiology and aetiology of heart failure , 2016, Nature Reviews Cardiology.

[26]  Rury R Holman,et al.  Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.

[27]  J. Tu,et al.  Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. , 2002, Archives of internal medicine.

[28]  R. Goldberg,et al.  Long-term survival after heart failure: a contemporary population-based perspective. , 2007, Archives of internal medicine.

[29]  M. Nelson,et al.  Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the Second Australian National Blood Pressure study cohort. , 2010, Age and ageing.

[30]  G. Fonarow,et al.  Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. , 2008, Journal of cardiac failure.

[31]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[32]  L. Køber,et al.  Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. , 2004, European heart journal.

[33]  B. Davis,et al.  Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial , 2012, Journal of clinical hypertension.

[34]  Andrew J S Coats,et al.  Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. , 2003, Journal of cardiac failure.

[35]  J. Aviña-Zubieta,et al.  Validity of Heart Failure Diagnoses in Administrative Databases: A Systematic Review and Meta-Analysis , 2014, PloS one.

[36]  A. Dobson,et al.  Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts , 2016, Journal of hypertension.

[37]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[38]  Ruoxiang Jiang,et al.  A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. , 2015, JAMA internal medicine.